TRNS

Transcat, Inc.

Industrials · $821M market cap

Verdict

Share price

$90.39

close of Oct 3, 2026

Fair value

$43.62

Sticker Price

Payback Price

$17.45

buy price

Overpriced

TRNS is Overpriced: at $90.39 it trades 107% above its fair value of $43.62. Its buy price (Payback Price) is $17.45, 81% below today's price. Business quality is solid: 3 of 5 key numbers clear the 10% bar.

How we valued it

Free Cash Flow. Sales grew 13% a year over the last 3 years, below the 15% we look for in a fast grower, so we value it on its free cash flow instead of an earnings forecast.

Business quality

3 of 5 clear the 10% bar. What are the Big Five?

Earnings per share growth12.1% a year✓
Equity per share growth13.2% a year✓
Sales growth8.1% a year✗
Free cash flow growth11.9% a year✓
Return on invested capital3.9%✗

Follow TRNS

Get notified when it reaches its buy price of $17.45. Free.

Create a free account

Superinvestors

1 of the investors we track holds TRNS. In Q2 2026, 1 added. Who we track

Moves in Q2 2026

Added: First Eagle Investment Management

Insider activity

Since Jun 22, 2026: 1 open-market purchase worth $99K, 2 sales worth $673K and 19 other filings (stock awards, tax withholding and similar). Why purchases matter

Purchases

Sales

Other filings

About Transcat, Inc.

Transcat, Inc. is a provider of accredited calibration and laboratory instrument services, and a value-added distributor of professional grade test, measurement, and control instrumentation. The company operates through two segments, Service and Distribution, and focuses on providing services and products to highly regulated industries, particularly the life science industry, which includes pharmaceutical…

Specialty Business Services

Fair value and Payback Price are estimates from the company's reported financials, not investment advice. Prices as of the close of Oct 3, 2026. How the Payback Price works